House Cosmetics Bill Imminent With Small – And Big – Business Support
This article was originally published in The Rose Sheet
Executive Summary
A second bill to enhance FDA's oversight of the cosmetics industry is expected to be introduced in the next few weeks, according to Independent Cosmetic Manufacturers and Distributors President and CEO Pam Busiek. The bill will launch in the House – likely with bipartisan support – and be modeled after 2012's Cosmetic Safety Amendments Act, she said.
You may also be interested in...
In Brief: Alternate Cosmetics Bill Pushed Back; ECHA Finds Unapproved Animal Tests; More
An awaited alternative to the controversial Personal Care Products Safety Act is now expected to emerge after Congress's summer recess, ICMAD President Pam Busiek says. More news in brief.
Editorial: Will Next Anti-Aging Market Disruptor Be Anti-Anti-Aging?
"The Rose Sheet" makes a case for the theoretical Dollar Anti-Aging Club and why updating the FDCA's "cosmetic" definition as part of broader regulatory reform could be in industry's interest.
Feinstein Bill Lacks ‘Crucial’ National Uniformity Assurance – ICMAD
Small-business trade group the Independent Cosmetic Manufacturers and Distributors says the Personal Care Products Safety Act would place an undue burden on small businesses and fails to address national uniformity issues. In an interview with “The Rose Sheet,” ICMAD President and CEO Pam Busiek discussed the group’s opposition to the bill and suggested that 2012’s Cosmetic Safety Amendments Act would have been a better starting point for legislation.